JPWO2022092141A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022092141A5
JPWO2022092141A5 JP2022559192A JP2022559192A JPWO2022092141A5 JP WO2022092141 A5 JPWO2022092141 A5 JP WO2022092141A5 JP 2022559192 A JP2022559192 A JP 2022559192A JP 2022559192 A JP2022559192 A JP 2022559192A JP WO2022092141 A5 JPWO2022092141 A5 JP WO2022092141A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
compound
pharmaceutically acceptable
aromatic heterocyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022559192A
Other languages
English (en)
Japanese (ja)
Other versions
JP7358657B2 (ja
JPWO2022092141A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/039623 external-priority patent/WO2022092141A1/ja
Publication of JPWO2022092141A1 publication Critical patent/JPWO2022092141A1/ja
Publication of JPWO2022092141A5 publication Critical patent/JPWO2022092141A5/ja
Application granted granted Critical
Publication of JP7358657B2 publication Critical patent/JP7358657B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022559192A 2020-10-28 2021-10-27 抗ウイルス活性を有するアミド誘導体 Active JP7358657B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020180856 2020-10-28
JP2020180856 2020-10-28
PCT/JP2021/039623 WO2022092141A1 (ja) 2020-10-28 2021-10-27 抗ウイルス活性を有するアミド誘導体

Publications (3)

Publication Number Publication Date
JPWO2022092141A1 JPWO2022092141A1 (https=) 2022-05-05
JPWO2022092141A5 true JPWO2022092141A5 (https=) 2023-07-13
JP7358657B2 JP7358657B2 (ja) 2023-10-10

Family

ID=81382618

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022559192A Active JP7358657B2 (ja) 2020-10-28 2021-10-27 抗ウイルス活性を有するアミド誘導体

Country Status (13)

Country Link
US (1) US12528790B2 (https=)
EP (1) EP4238960A4 (https=)
JP (1) JP7358657B2 (https=)
KR (1) KR102734880B1 (https=)
CN (3) CN121021491A (https=)
AU (1) AU2021368444B2 (https=)
CA (1) CA3200111C (https=)
CO (1) CO2023005496A2 (https=)
IL (1) IL302458B2 (https=)
MX (1) MX2023004779A (https=)
TW (1) TWI839652B (https=)
WO (1) WO2022092141A1 (https=)
ZA (1) ZA202305385B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3200111C (en) * 2020-10-28 2025-02-18 Shionogi & Co., Ltd. AMIDE DERIVATIVE WITH ANTIVIRAL ACTIVITY
CN119060016B (zh) * 2023-12-14 2025-07-29 杭州师范大学 具有rsv抑制活性的酰胺衍生物及其制备方法和应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001027105A1 (en) * 1999-10-12 2001-04-19 Takeda Chemical Industries, Ltd. Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof
SE0302232D0 (sv) * 2003-08-18 2003-08-18 Astrazeneca Ab Novel Compounds
US20070238718A1 (en) 2006-04-06 2007-10-11 Matthias Grauert Thiazolyl-dihydro-indazole
TWI515187B (zh) 2010-12-16 2016-01-01 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之吲哚類
US9388140B2 (en) 2011-03-31 2016-07-12 Bayer Intellectual Property Gmbh Substituted benzimidazoles
AU2013249280B2 (en) * 2012-04-17 2017-10-12 Gilead Sciences, Inc. Compounds and methods for antiviral treatment
EA201590197A1 (ru) * 2012-08-23 2015-07-30 Алиос Биофарма, Инк. Соединения для лечения парамиксовирусных вирусных инфекций
JP6237779B2 (ja) 2012-11-03 2017-11-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング サイトメガロウイルスの阻害薬
EP2997028A1 (en) * 2013-05-14 2016-03-23 F.Hoffmann-La Roche Ag Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection
AU2014308991B2 (en) 2013-08-21 2019-02-14 Janssen Biopharma, Inc. Antiviral compounds
MA41614A (fr) 2015-02-25 2018-01-02 Alios Biopharma Inc Composés antiviraux
JP2018076234A (ja) 2015-03-16 2018-05-17 大正製薬株式会社 ピラゾロ[1,5−a]ピリミジン化合物
JO3637B1 (ar) 2015-04-28 2020-08-27 Janssen Sciences Ireland Uc مركبات بيرازولو- وترايازولو- بيريميدين مضادة للفيروسات rsv
WO2017196982A1 (en) 2016-05-10 2017-11-16 Georgia State University Research Foundation, Inc. Bicyclic fused pyrazole derivatives for the treatment of rsv
TW201932470A (zh) 2017-11-29 2019-08-16 愛爾蘭商健生科學愛爾蘭無限公司 具有抗rsv活性之吡唑并嘧啶
TW201936193A (zh) 2017-12-05 2019-09-16 愛爾蘭商健生科學愛爾蘭無限公司 使用組合產品治療rsv
SG11202006141RA (en) 2018-01-31 2020-07-29 Janssen Sciences Ireland Unlimited Co Cycloalkyl substituted pyrazolopyrimidines having activity against rsv
US11708369B2 (en) 2018-04-23 2023-07-25 Janssen Sciences Ireland Unlimited Company Heteroaromatic compounds having activity against RSV
EA202191482A1 (ru) 2018-11-26 2021-12-14 Янссен Сайенсиз Айрлэнд Анлимитед Компани Другие гетероароматические соединения, обладающие активностью против rsv
EA202193223A1 (ru) 2019-05-23 2022-03-10 Янссен Сайенсиз Айрлэнд Анлимитед Компани Другие гетероароматические соединения, действующие против рсв
AU2020357452B2 (en) 2019-10-04 2026-01-29 Enanta Pharmaceuticals, Inc Antiviral heterocyclic compounds
UY39032A (es) 2020-01-24 2021-07-30 Enanta Pharm Inc Compuestos heterocíclicos como agentes antivirales
WO2021198981A1 (en) 2020-04-01 2021-10-07 Janssen Biopharma, Inc. Antiviral compounds and uses thereof
JP2023522091A (ja) 2020-04-21 2023-05-26 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー Rsv阻害性の3置換キノリン及びシンノリン誘導体
US11945824B2 (en) 2020-10-19 2024-04-02 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as anti-viral agents
CA3200111C (en) * 2020-10-28 2025-02-18 Shionogi & Co., Ltd. AMIDE DERIVATIVE WITH ANTIVIRAL ACTIVITY
WO2022182861A1 (en) 2021-02-26 2022-09-01 Enanta Pharmaceuticals, Inc. Antiviral heterocyclic compounds
WO2022211812A1 (en) 2021-04-01 2022-10-06 Enanta Pharmaceuticals, Inc. Antiviral heterocyclic compounds

Similar Documents

Publication Publication Date Title
RU2308455C2 (ru) Аминопиримидины и пиридины
JP4061332B2 (ja) 新規チアゾリジン−4−オン誘導体
JPWO2022092141A5 (https=)
JP2022512588A5 (https=)
JP2008510828A5 (https=)
JP2005526076A5 (https=)
JP2020506178A5 (https=)
FI81096B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 2-(n-substituerad guanidino)-4-heteroaryltiazolfoereningar.
JP2004525150A5 (https=)
JP2011519910A5 (https=)
JP2023520916A5 (https=)
JP2002526516A5 (https=)
CN100369903C (zh) 五元环化合物
JP2011219498A5 (https=)
JP2018536648A5 (https=)
PT96234A (pt) Agentes inibidores da protease de hiv uteis no tratamento da sida
JP2009519243A5 (https=)
JP2012528839A5 (https=)
JP2020502047A5 (https=)
JP2018531987A5 (https=)
JP2005530811A5 (https=)
JP2013515037A5 (https=)
JP2005511545A5 (https=)
JP2020128426A5 (https=)
JPWO2023106310A5 (https=)